Magnetic resonance imaging evidence of 'silent' cerebrovascular toxicity in cocaine dependence

Biological Psychiatry

Volumn 45, Issue 9, 1999, Pages 1203-1211

  Bartzokis, George ^a,b,c   Beckson, Mace ^c,d   Hance, Darwood B ^d   Lu, Po H ^c   Foster, Jennifer A ^c   Mintz, Jim ^c,d   Ling, Walter ^c,d   Bridge, Peter ^e  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Aging; Cocaine; Hyperintense lesions; Magnetic resonance imaging

Indexed keywords

COCAINE;

ADULT; ARTICLE; BRAIN REGION; CEREBROVASCULAR DISEASE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE SEVERITY; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

ADULT; AGE FACTORS; BRAIN; COCAINE-RELATED DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 0033134962     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00228-5     Document Type: Article

References (74)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
2. Andrews P. Cocaethylene toxicity. J Addict Dis. 16:1997;75-84.
3. Atack J.R., Perry E.K., Bonham J.R., Candy J.M., Perry R.H. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem. 47:1986;263-277.
4. Awad I.A., Johnson P.C., Spetzler R.F., Hodak J.A. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke. 17:1986;1090-1097.
5. Barroso-Moguel R., Villeda-Hernandez J., Mendez-Armenta M., Rios C. Brain capillary lesions produced by cocaine in rats. Toxicol Lett. 92:1997;9-14.
6. Bartzokis G., Beckson M., Ling W. Clinical and MRI evaluation of psychostimulant neurotoxicity. NIDA Res Monogr. 163:1996;300-317.
7. Bauman J.L., Grawe J.J., Winecoff A.P., Hariman R.J. Cocaine-related sudden cardiac death: A hypothesis correlating basic science and clinical observations. J Clin Pharmacol. 34:1994;902-911.
8. Benowitz NL (1993): Clinical pharmacology and toxicology of cocaine [published erratum appears in Pharmacol Toxicol 1993;72:343]. Pharmacol Toxicol 72:3-12.
9. Benowitz NL (1993): Clinical pharmacology and toxicology of cocaine [published erratum appears in Pharmacol Toxicol 1993;72:343]. Pharmacol Toxicol 72:3-12.
10. Berry J., van Gorp W.G., Herzberg D.S., Hinkin C., Boone K., Steinman L., et al. Neuropsychological deficits in abstinent cocaine abusers: Preliminary findings after two weeks of abstinence. Drug Alcohol Depend. 32:1993;231-237.
11. Bogousslavsky J., Regli F. Centrum ovale infarcts: Subcortical infarction in the superficial territory of the middle cerebral artery. Neurology. 42:1992;1992-1998. [see comments].
12. Borlongan C.V., Cahill D.W., Sanberg P.R. Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery. Physiol Behav. 58:1995;909-917.
13. Borlongan C.V., Martinez R., Shytle R.D., Freeman T.B., Cahill D.W., Sanberg P.R. Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery. Pharmacol Biochem Behav. 52:1995;225-229.
14. Brown J.J., Hesselink J.R., Rothrock J.F. MR and CT of lacunar infarcts. AJR Am J Roentgenol. 151:1988;367-372.
15. Brown E., Prager J., Lee H.Y., Ramsey R.G. CNS complications of cocaine abuse: Prevalence, pathophysiology, and neuroradiology. AJR Am J Roentgenol. 159:1992;137-147.
16. Carmona G.N., Baum I., Schindler C.W., Goldberg S.R., Jufer R., Cone E., et al. Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys. Life Sci. 59:1996;939-943.
17. Cone E.J., Hillsgrove M., Darwin W.D. Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin Chem. 40:1994;1299-1305.
18. Copeland J.R., Willoughby K.A., Police R.J., Ellis E.F. Repeated cocaine administration reduces bradykinin-induced dilation of pial arterioles. Am J Physiol. 271:1996;H1576-H1583.
19. Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol. 40:1983;138-142.
20. Damasio A.R., Damasio H., Rizzo M., Varney N., Gersh F. Aphasia with nonhemorrhagic lesions in the basal ganglia and internal capsule. Arch Neurol. 39:1982;15-24.
21. Daras M., Tuchman A.J., Koppel B.S., Samkoff L.M., Weitzner I., Marc J. Neurovascular complications of cocaine. Acta Neurol Scand. 90:1994;124-129.
22. Erzouki H.K., Baum I., Goldberg S.R., Schindler C.W. Comparison of the effects of cocaine and its metabolites on cardiovascular function in anesthetized rats. J Cardiovasc Pharmacol. 22:1993;557-563.
23. Fazekas F., Fazekas G., Schmidt R., Kapeller P., Offenbacher H. Magnetic resonance imaging correlates of transient cerebral ischemic attacks. Stroke. 27:1996;607-611.
24. Fessler R.D., Esshaki C.M., Stankewitz R.C., Johnson R.R., Diaz F.G. The neurovascular complications of cocaine. Surg Neurol. 47:1997;339-345.
25. Friede R.L. A comparative histochemical mapping of the distribution of butyryl cholinesterase in the brains of four species of mammals, including man. Acta Anat (Basel). 66:1967;161-177.
26. Fushimi H., Inoue T., Yamada Y., Udaka F., Kameyama M. Asymptomatic cerebral small infarcts (lacunae), their risk factors and intellectual disturbances. Diabetes. 45:(suppl 3):1996;S98-S100.
27. Garcia J.H., Lassen N.A., Weiller C., Sperling B., Nakagawara J. Ischemic stroke and incomplete infarction. Stroke. 27:1996;761-765.
28. Gatley S.J., Yu D.W., Fowler J.S., MacGregor R.R., Schlyer D.J., Dewey S.L., et al. Studies with differentially labeled [11C]cocaine, [11C]norcocaine, [11C]benzoylecgonine, and [11C]- and 4′-[18F]fluorococaine to probe the extent to which [11C]cocaine metabolites contribute to PET images of the baboon brain. J Neurochem. 62:1994;1154-1162.
29. Gawin F.H., Kleber H.D. Medical Management of Cocaine Withdrawal. 1986;Werber/Mystad Associates, New York.
30. Hass W.K., Easton J.D., Adams H.P.J., Pryse-Phillips W., Molony B.A., Anderson S., et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. [Ticlopidine Aspirin Stroke Study Group; see comments]. N Engl J Med. 321:1989;501-507.
31. Havranek E.P., Nademanee K., Grayburn P.A., Eichhorn E.J. Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy. J Am Coll Cardiol. 28:1996;1168-1174.
32. He G.Q., Zhang A., Altura B.T., Altura B.M. Cocaine-induced cerebrovasospasm and its possible mechanism of action. J Pharmacol Exp Ther. 268:1994;1532-1539.
33. Hedaya M.A., Pan W.J. Cocaine and alcohol interactions in naive and alcohol-pretreated rats. Drug Metab Dispos Biol Fate Chem. 24:1996;807-812.
34. Hoff A.L., Riordan H., Morris L., Cestaro V., Wieneke M., Alpert R., et al. Effects of crack cocaine on neurocognitive function. Psychiatry Res. 60:1996;167-176.
35. Isenschmid D.S., Fischman M.W., Foltin R.W., Caplan Y.H. Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine [see comments]. J Anal Toxicol. 16:1992;311-314.
36. Isner J.M., Chokshi S.K. Cocaine and vasospasm [editorial; comment]. N Engl J Med. 321:1989;1604-1606.
37. Jacobs I.G., Roszler M.H., Kelly J.K., Klein M.A., Kling G.A. Cocaine abuse: Neurovascular complications. Radiology. 170:1989;223-227.
38. Jbilo O., Bartels C.F., Chatonnet A., Toutant J.P., Lockridge O. Tissue distribution of human acetylcholinesterase and butyrylcholinesterase messenger RNA. Toxicon. 32:1994;1445-1457.
39. Kaufman MJ, Levin JM, Ross M, Lange N, Rose SL, Kukes TJ, et al (1997): Cocaine-induced cerebral vasospasm in humans: Detection with magnetic resonance angiography. In: Harris L, editor. National Institute on Drug Abuse Research monograph series 178: Problems of drug dependence 1997: Proceedings of the 59th annual scientific meeting, The College on Problems of Drug Dependence Inc. Rockville: U.S. Dept. of Health and Human Services, National Institutes of Health: 106.
40. Kobari M., Meyer J.S., Ichijo M., Oravez W.T. Leukoaraiosis: Correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol. 11:1990;273-281.
41. Kokkinos J., Levine S.R. Stroke. Neurol Clin. 11:1993;577-590.
42. Konzen J.P., Levine S.R., Garcia J.H. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine [see comments]. Stroke. 26:1995;1114-1118.
43. Kukes T.J., Kaufman M.J., Levin J.M., Maas L.C., Rose S.L., Mendelson J.H., et al. Cocaine-induced cerebral blood volume reduction in females. Harris L. National Institute on Drug Abuse Research monograph series 178 Problems of drug dependence 1997: Proceedings of the 59th annual scientific meeting, The College on Problems of Drug Dependence Inc . 1997;154 U.S. Dept. of Health and Human Services, National Institutes of Health, Rockville.
44. Levine S.R., Brust J.C., Futrell N., Ho K.L., Blake D., Millikan C.H., et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine [comment]. N Engl J Med. 323:1990;699-704.
45. Levine S.R., Welch K.M.A. Cocaine and stroke. Stroke. 19:1996;779-783.
46. Lin Y., Leskawa K.C. Cytotoxicity of the cocaine metabolite benzoylecgonine. Brain Res. 643:1994;108-114.
47. Lumsden C.E. The problem of correlation of quantitative methods and tissue morphology in the central nervous system: The distribution of cholinesterases. Richter D. Metabolism of the Nervous System. 1957;91-100 Plenum Press, New York.
48. Madden J.A., Konkol R.J., Keller P.A., Alvarez T.A. Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms. Life Sci. 56:1995;679-686.
49. Marzuk P.M., Tardiff K., Leon A.C., Hirsch C.S., Stajic M., Portera L., et al. Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Engl J Med. 332:1995;1753-1757.
50. Mendal B., Rudney H. Butyrylcholinestrase in the white matter. J Biochem. 43:1953;59-63.
51. Mineura K., Sasajima H., Kikuchi K., Kowada M., Tomura N., Monma K., et al. White matter hyperintensity in neurologically asymptomatic subjects. Acta Neurol Scand. 92:1995;151-156.
52. Moody D.M., Bell M.A., Challa V.R. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: An anatomic study. AJNR Am J Neuroradiol. 11:1990;431-439.
53. Nolte K.B., Brass L.M., Fletterick C.F. Intracranial hemorrhage associated with cocaine abuse: A prospective autopsy study. Neurology. 46:1996;1291-1296.
54. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis [see comments]. N Engl J Med. 325:1991;445-453.
55. O'Malley S., Adamse M., Heaton R.K., Gawin F.H. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse. 18:1992;131-144.
56. Oppenheimer S.M., Kedem G., Martin W.M. Left-insular cortex lesions perturb cardiac autonomic tone in humans. Clin Auton Res. 6:1996;131-140.
57. Pasquier F., Leys D. Why are stroke patients prone to develop dementia? J Neurol. 244:1997;135-142.
58. Qureshi A.I., Akbar M.S., Czander E., Safdar K., Janssen R.S., Frankel M.R. Crack cocaine use and stroke in young patients. Neurology. 48:1997;341-345.
59. Saady J.J., Bowman E.R., Aceto M.D. Cocaine, ecgonine methyl ester, and benzoylecgonine plasma profiles in rhesus monkeys. J Anal Toxicol. 19:1995;571-575.
60. Schuelke G.S., Konkol R.J., Terry L.C., Madden J.A. Effect of cocaine metabolites on behavior: Possible neuroendocrine mechanisms. Brain Res Bull. 39:1996;43-48.
61. Sette G., Baron J.C., Young A.R., Miyazawa H., Tillet I., Barre L., et al. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke. 24:1993;2046-2057.
62. Shellshear J.L. The basal arteries of the forebrain and their functional significance. J Anat. LV:1921;27-35.
63. Shen W.K., Edwards W.D., Hammill S.C., Bailey K.R., Ballard D.J., Gersh B.J. Sudden unexpected nontraumatic death in 54 young adults: A 30-year population-based study. Am J Cardiol. 76:1995;148-152.
64. Spiehler V.R., Reed D. Brain concentrations of cocaine and benzoylecgonine in fatal cases. J Forensic Sci. 30:1985;1003-1011.
65. Strickland T.L., Mena I., Villanueva-Meyer J., Miller B.L., Cummings J., Mehringer C.M., et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 5:1993;419-427.
66. Tumeh S.S., Nagel J.S., English R.J., Moore M., Holman B.L. Cerebral abnormalities in cocaine abusers: Demonstration by SPECT perfusion brain scintigraphy. Work in progress. Radiology. 176:1990;821-824.
67. van Swieten J.C., Staal S., Kappelle L.J., Derix M.M., van Gijn J. Are white matter lesions directly associated with cognitive impairment in patients with lacunar infarcts? J Neurol. 243:1996;196-200.
68. Volkow N.D., Mullani N., Gould K.L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. Br J Psychiatry. 152:1988;641-648.
69. Volkow N.D., Valentine A., Kulkarni M. Radiological and neurological changes in the drug abuse patient: A study with MRI. J Neuroradiol. 15:1988;288-293.
70. Wallace E.A., Wisniewski G., Zubal G., van Dyck C.H., Pfau S.E., Smith E.O., et al. Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology (Berl). 128:1996;17-20.
71. Weber D.A., Franceschi D., Ivanovic M., Atkins H.L., Cabahug C., Wong C.T., et al. SPECT and planar brain imaging in crack abuse: Iodine-123-iodoamphetamine uptake and localization. J Nucl Med. 34:1993;899-907.
72. Weiss R.D., Gawin F.H. Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. Am J Med. 85:1988;879-880.
73. Wright C.I., Geula C., Mesulam M.M. Neurological cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles, and patterns of selective vulnerability. Ann Neurol. 34:1993;373-384.
74. Yetkin F.Z., Haughton V.M., Fischer M.E., Papke R.A., Daniels D.L., Mark L.P., et al. High-signal foci on MR images of the brain: Observer variability in their quantification. AJR Am J Roentgenol. 159:1992;185-188.